Drug
Rdc 0313 Buprenorphine
Rdc 0313 Buprenorphine: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| RDC-0313 + Buprenorphine NCT01046539 | Phase 1 | Substance-Related Disorders |
Latest
No recent events.
Follow Rdc 0313 Buprenorphine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.